Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome
SJ Bonnema, L Hegedüs - Endocrine reviews, 2012 - academic.oup.com
Radioiodine (131I) therapy of benign thyroid diseases was introduced 70 yr ago, and the
patients treated since then are probably numbered in the millions. Fifty to 90% of …
patients treated since then are probably numbered in the millions. Fifty to 90% of …
The role of radioiodine therapy in benign nodular goitre
SJ Bonnema, S Fast, L Hegedüs - Best Practice & Research Clinical …, 2014 - Elsevier
For treatment of benign nodular goitre the choice usually stands between surgery and 131 I
therapy. 131 I therapy, used for 30 years for this condition, leads to a goitre volume reduction …
therapy. 131 I therapy, used for 30 years for this condition, leads to a goitre volume reduction …
Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter
S Fast, VE Nielsen, P Grupe… - The Journal of …, 2012 - academic.oup.com
Objective: The objective of the study was to evaluate the long-term outcome of recombinant
human TSH (rhTSH)-augmented radioiodine (131I) therapy for benign multinodular nontoxic …
human TSH (rhTSH)-augmented radioiodine (131I) therapy for benign multinodular nontoxic …
Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International …
H Graf, S Fast, F Pacini, A Pinchera… - The Journal of …, 2011 - academic.oup.com
Background: Recombinant human TSH (rhTSH) can be used to enhance 131I therapy for
shrinkage of multinodular goiter (MG). Objective, Design, and Setting: The objective of the …
shrinkage of multinodular goiter (MG). Objective, Design, and Setting: The objective of the …
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter …
S Fast, L Hegedüs, F Pacini, A Pinchera, AM Leung… - Thyroid, 2014 - liebertpub.com
Background: Enhanced reduction of multinodular goiter (MNG) can be achieved by
stimulation with recombinant human thyrotropin (rhTSH) before radioiodine (131I) therapy …
stimulation with recombinant human thyrotropin (rhTSH) before radioiodine (131I) therapy …
Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy
SJ Bonnema, S Fast, L Hegedüs - Endocrine, 2011 - Springer
The optimal treatment strategy in a goiter patient depends—among other factors—on goiter
size, the degree of cosmetic or compressive symptoms, the age of the patient, the impact on …
size, the degree of cosmetic or compressive symptoms, the age of the patient, the impact on …
Recombinant human thyrotropin before 131I therapy in patients with nodular goitre: a meta‐analysis of randomized controlled trials
YY Lee, KW Tam, YM Lin, WJ Leu… - Clinical …, 2015 - Wiley Online Library
Background Recombinant human thyrotropin (rhTSH) can be used to enhance radioiodine
therapy for shrinking multinodular goitre. The aim of this meta‐analysis was to compare the …
therapy for shrinking multinodular goitre. The aim of this meta‐analysis was to compare the …
Therapy of Endocrine Disease: Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter
H Graf - European Journal of Endocrinology, 2015 - academic.oup.com
Multinodular goiter (MNG) is a very common thyroid disorder determined by diverse
goitrogenic factors, the most important one being iodine deficiency. The clinical presentation …
goitrogenic factors, the most important one being iodine deficiency. The clinical presentation …
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre
In multinodular goitre (MNG), low radioiodine (RAI) activity after recombinant human (rh)
TSH is able to reduce thyroid volume (TV) and improve symptoms. Our aim was to evaluate …
TSH is able to reduce thyroid volume (TV) and improve symptoms. Our aim was to evaluate …
Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH
S Fast, SJ Bonnema, L Hegedüs - Annales D'endocrinologie, 2011 - Elsevier
This review provides an update on recombinant human TSH (rh-TSH) augmented
radioiodine (131 I) therapy and outlines its potential role in the treatment of symptomatic …
radioiodine (131 I) therapy and outlines its potential role in the treatment of symptomatic …